Effect of intracarotid and intraventricular morphine on regional cerebral blood flow and metabolism in pentobarbital-anesthetized dogs

P. J. Hoehner, J. T. Whitson, Jeffrey Kirsch, R. J. Traystman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Potent opiate analgesics, administered either epidurally, intrathecally, or intravenously, are a common adjunct to pain control in the perioperative period. Little is known, however, of the effects of opiate agonists on cerebral blood flow (CBF) and metabolism. Current studies are complicated by the hypotensive effects of these compounds and their route of administration. To circumvent these difficulties we studied the effects of intraventricular and intracarotid morphine sulfate, in doses that do not affect arterial blood pressure, on regional CBF and total cerebral oxygen consumption (CMRO2) in pentobarbital-anesthetized dogs. Five dogs received 0.04 mg/kg morphine via intracarotid injection. Five additional dogs received 0.2 mg/kg morphine via ventricular cisternal infusion over 5 min, and five control dogs received mock cerebrospinal fluid at the same infusion rate. CBF was measured using the radiolabeled microsphere technique. Intracarotid morphine decreased neurohypophyseal blood flow to 58% of control, but it did not alter blood flow to any other brain region, except caudate nucleus, or cause a change in CMRO2. Infusion of mock cerebrospinal fluid in the cerebral ventricles did not alter CBF or CMRO2. Ventricular-cisternal perfusion of morphine caused a transient increase in CBF (24 ± 2 to 37 ± 6 mL min-1 100 kg-1) but had no effect on spinal cord blood flow or CMRO2. Neurohypophyseal blood flow, however, decreased to 40% of control levels (480 ± 76 to 176 ± 42 mL min- 1 100 kg-1) after 2 min and gradually returned to control levels at 60 min. These data demonstrate that intracarotid and intraventricular morphine decreased blood flow to neurohypophysis, but only ventricular-cisternal perfusion of morphine altered blood flow to other brain regions, with the exception of caudate nucleus. Our results suggest a role for opiates in the control of CBF independent of changes in CMRO2 when administered directly into the cerebrospinal fluid. This may have clinical implications when opiates are administered intrathecally or intravenously under conditions when the blood-brain barrier is disrupted. Opiates may also play a role in regulation of neurohypophyseal blood flow.

Original languageEnglish (US)
Pages (from-to)266-273
Number of pages8
JournalAnesthesia and Analgesia
Volume76
Issue number2
StatePublished - 1993
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Opiate Alkaloids
Regional Blood Flow
Pentobarbital
Morphine
Dogs
Cerebrospinal Fluid
Caudate Nucleus
Perfusion
Posterior Pituitary Gland
Cerebral Ventricles
Perioperative Period
Brain
Blood-Brain Barrier
Fetal Blood
Microspheres
Oxygen Consumption
Analgesics
Spinal Cord
Arterial Pressure

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Effect of intracarotid and intraventricular morphine on regional cerebral blood flow and metabolism in pentobarbital-anesthetized dogs. / Hoehner, P. J.; Whitson, J. T.; Kirsch, Jeffrey; Traystman, R. J.

In: Anesthesia and Analgesia, Vol. 76, No. 2, 1993, p. 266-273.

Research output: Contribution to journalArticle

@article{d8f575858f2a4d6db752fdf78e1df83b,
title = "Effect of intracarotid and intraventricular morphine on regional cerebral blood flow and metabolism in pentobarbital-anesthetized dogs",
abstract = "Potent opiate analgesics, administered either epidurally, intrathecally, or intravenously, are a common adjunct to pain control in the perioperative period. Little is known, however, of the effects of opiate agonists on cerebral blood flow (CBF) and metabolism. Current studies are complicated by the hypotensive effects of these compounds and their route of administration. To circumvent these difficulties we studied the effects of intraventricular and intracarotid morphine sulfate, in doses that do not affect arterial blood pressure, on regional CBF and total cerebral oxygen consumption (CMRO2) in pentobarbital-anesthetized dogs. Five dogs received 0.04 mg/kg morphine via intracarotid injection. Five additional dogs received 0.2 mg/kg morphine via ventricular cisternal infusion over 5 min, and five control dogs received mock cerebrospinal fluid at the same infusion rate. CBF was measured using the radiolabeled microsphere technique. Intracarotid morphine decreased neurohypophyseal blood flow to 58{\%} of control, but it did not alter blood flow to any other brain region, except caudate nucleus, or cause a change in CMRO2. Infusion of mock cerebrospinal fluid in the cerebral ventricles did not alter CBF or CMRO2. Ventricular-cisternal perfusion of morphine caused a transient increase in CBF (24 ± 2 to 37 ± 6 mL min-1 100 kg-1) but had no effect on spinal cord blood flow or CMRO2. Neurohypophyseal blood flow, however, decreased to 40{\%} of control levels (480 ± 76 to 176 ± 42 mL min- 1 100 kg-1) after 2 min and gradually returned to control levels at 60 min. These data demonstrate that intracarotid and intraventricular morphine decreased blood flow to neurohypophysis, but only ventricular-cisternal perfusion of morphine altered blood flow to other brain regions, with the exception of caudate nucleus. Our results suggest a role for opiates in the control of CBF independent of changes in CMRO2 when administered directly into the cerebrospinal fluid. This may have clinical implications when opiates are administered intrathecally or intravenously under conditions when the blood-brain barrier is disrupted. Opiates may also play a role in regulation of neurohypophyseal blood flow.",
author = "Hoehner, {P. J.} and Whitson, {J. T.} and Jeffrey Kirsch and Traystman, {R. J.}",
year = "1993",
language = "English (US)",
volume = "76",
pages = "266--273",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effect of intracarotid and intraventricular morphine on regional cerebral blood flow and metabolism in pentobarbital-anesthetized dogs

AU - Hoehner, P. J.

AU - Whitson, J. T.

AU - Kirsch, Jeffrey

AU - Traystman, R. J.

PY - 1993

Y1 - 1993

N2 - Potent opiate analgesics, administered either epidurally, intrathecally, or intravenously, are a common adjunct to pain control in the perioperative period. Little is known, however, of the effects of opiate agonists on cerebral blood flow (CBF) and metabolism. Current studies are complicated by the hypotensive effects of these compounds and their route of administration. To circumvent these difficulties we studied the effects of intraventricular and intracarotid morphine sulfate, in doses that do not affect arterial blood pressure, on regional CBF and total cerebral oxygen consumption (CMRO2) in pentobarbital-anesthetized dogs. Five dogs received 0.04 mg/kg morphine via intracarotid injection. Five additional dogs received 0.2 mg/kg morphine via ventricular cisternal infusion over 5 min, and five control dogs received mock cerebrospinal fluid at the same infusion rate. CBF was measured using the radiolabeled microsphere technique. Intracarotid morphine decreased neurohypophyseal blood flow to 58% of control, but it did not alter blood flow to any other brain region, except caudate nucleus, or cause a change in CMRO2. Infusion of mock cerebrospinal fluid in the cerebral ventricles did not alter CBF or CMRO2. Ventricular-cisternal perfusion of morphine caused a transient increase in CBF (24 ± 2 to 37 ± 6 mL min-1 100 kg-1) but had no effect on spinal cord blood flow or CMRO2. Neurohypophyseal blood flow, however, decreased to 40% of control levels (480 ± 76 to 176 ± 42 mL min- 1 100 kg-1) after 2 min and gradually returned to control levels at 60 min. These data demonstrate that intracarotid and intraventricular morphine decreased blood flow to neurohypophysis, but only ventricular-cisternal perfusion of morphine altered blood flow to other brain regions, with the exception of caudate nucleus. Our results suggest a role for opiates in the control of CBF independent of changes in CMRO2 when administered directly into the cerebrospinal fluid. This may have clinical implications when opiates are administered intrathecally or intravenously under conditions when the blood-brain barrier is disrupted. Opiates may also play a role in regulation of neurohypophyseal blood flow.

AB - Potent opiate analgesics, administered either epidurally, intrathecally, or intravenously, are a common adjunct to pain control in the perioperative period. Little is known, however, of the effects of opiate agonists on cerebral blood flow (CBF) and metabolism. Current studies are complicated by the hypotensive effects of these compounds and their route of administration. To circumvent these difficulties we studied the effects of intraventricular and intracarotid morphine sulfate, in doses that do not affect arterial blood pressure, on regional CBF and total cerebral oxygen consumption (CMRO2) in pentobarbital-anesthetized dogs. Five dogs received 0.04 mg/kg morphine via intracarotid injection. Five additional dogs received 0.2 mg/kg morphine via ventricular cisternal infusion over 5 min, and five control dogs received mock cerebrospinal fluid at the same infusion rate. CBF was measured using the radiolabeled microsphere technique. Intracarotid morphine decreased neurohypophyseal blood flow to 58% of control, but it did not alter blood flow to any other brain region, except caudate nucleus, or cause a change in CMRO2. Infusion of mock cerebrospinal fluid in the cerebral ventricles did not alter CBF or CMRO2. Ventricular-cisternal perfusion of morphine caused a transient increase in CBF (24 ± 2 to 37 ± 6 mL min-1 100 kg-1) but had no effect on spinal cord blood flow or CMRO2. Neurohypophyseal blood flow, however, decreased to 40% of control levels (480 ± 76 to 176 ± 42 mL min- 1 100 kg-1) after 2 min and gradually returned to control levels at 60 min. These data demonstrate that intracarotid and intraventricular morphine decreased blood flow to neurohypophysis, but only ventricular-cisternal perfusion of morphine altered blood flow to other brain regions, with the exception of caudate nucleus. Our results suggest a role for opiates in the control of CBF independent of changes in CMRO2 when administered directly into the cerebrospinal fluid. This may have clinical implications when opiates are administered intrathecally or intravenously under conditions when the blood-brain barrier is disrupted. Opiates may also play a role in regulation of neurohypophyseal blood flow.

UR - http://www.scopus.com/inward/record.url?scp=0027465102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027465102&partnerID=8YFLogxK

M3 - Article

C2 - 8424502

AN - SCOPUS:0027465102

VL - 76

SP - 266

EP - 273

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -